Archive by category "News"

Detection of hepatocellular carcinoma in hepatitis C patients: Biomarker discovery by LC–MS

ABSTRACT: Hepatocellular carcinoma (HCC) accounts for most cases of liver cancer worldwide; contraction of hepatitis C (HCV) is considered a major risk factor for liver cancer even when individuals have not developed formal cirrhosis. Global, untargeted metabolic profiling methods were applied to serum samples from patients with either HCV alone or HCC (with underlying HCV). (continued…)

Continue Reading

Posted September 13, 2014 by Matrix-Bio • No Comments


Matrix-Bio to Present at InvestMidwest Venture Capital Forum

FORT WAYNE, Ind., March 19, 2014 – – Matrix Bio, Inc. announced today that Eric Beier, M.D., President and CEO, will present at the Invest Midwest Forum venture capital conference on March 27 in St. Louis, Missouri. Dr. Beier will discuss Matrix-Bio’s VeraMarker™ metabolite profiling technology for detection of the recurrence of colon cancer through (continued…)

Continue Reading

Posted March 18, 2014 by Melanie Lux • No Comments


Venture Summit West to Showcase Matrix-Bio, A Leader in Metabolomics-Based Cancer Diagnostics

FORT WAYNE, Ind., February 3, 2014 – – Matrix-Bio, Inc., a leader in the field of cancer diagnostics using metabolite profiling, is a featured startup company at the Second Annual Venture Summit West on February 13 in Mountain View, California. Matrix-Bio is seeking investment for a new colon cancer-monitoring test, which uses the company’s VeraMarker™ (continued…)

Continue Reading

Posted January 31, 2014 by Melanie Lux • No Comments


Matrix-Bio’s New Website Featuring Its Metabolite Profiling-Based Cancer Diagnostic Tests

FORT WAYNE, Ind., January 14, 2014 — Matrix-Bio, Inc., has launched a new website to showcase a growing portfolio of cancer diagnostics tests that utilize the company’s VeraMarker™ metabolite profiling technology and to engage the interest of investors and oncologists. Matrix-Bio, Inc. is a leader in the field of cancer diagnostics using metabolite profiling. Metabolite (continued…)

Continue Reading

Posted January 15, 2014 by Matrix-Bio • No Comments


Boston’s New England Venture Summit to Showcase Cancer Metabolomics Diagnostics Leader Matrix-Bio

FORT WAYNE, IND., December 6, 2013 – Matrix-Bio, Inc., a leader in the field of cancer diagnostics using metabolite profiling, is a featured startup company at the 8th annual New England Venture Summit on December 11 at the Hilton Boston Dedham. Download PDF

Continue Reading

Posted December 6, 2013 by Matrix-Bio • No Comments


Matrix-Bio Names Neff to Board of Directors

FORT WAYNE, IND., October 2, 2013 – Matrix-Bio, Inc., a leader in metabolomics-based cancer diagnostics, has named Deborah J. Neff to its Board of Directors. Palo Alto, California-based Neff is a veteran of the life sciences industry, with experience in building market-leading global businesses and product commercialization. Download PDF

Continue Reading

Posted October 2, 2013 by Matrix-Bio • No Comments


Indianapolis’ Midwest E3 Angel Investing Summit to Showcase Cancer Metabolomics Diagnostics Leader Matrix-Bio

FORT WAYNE, IND., September 10, 2013 – Matrix-Bio, Inc., a leader in the field of cancer diagnostics using metabolomics, is a featured startup company at the 2013 Midwest E3 Summit in Indianapolis, September 25 and 26. Download PDF

Continue Reading

Posted September 10, 2013 by Matrix-Bio • No Comments


Matrix-Bio’s CEO to Present at New Mexico Angels’ July Investors Showcase

FORT WAYNE, IND., July 17, 2013 – Matrix-Bio Chief Executive Officer Eric Beier, M.D., M.B.A., will be a featured presenter at the New Mexico Angels’ July Investors Showcase in Albuquerque and Santa Fe, New Mexico, held July 24 and 25 respectively. Download PDF

Continue Reading

Posted July 17, 2013 by Matrix-Bio • No Comments


Matrix-Bio’s CEO to Speak at Life Science Innovation Northwest, the Largest Biotech Event in Pacific Northwest

FORT WAYNE, IND., July 8, 2013 – Matrix-Bio Chief Executive Officer Eric Beier, M.D., M.B.A., is a featured speaker at Life Science Innovation Northwest 2013, the largest biotechnology conference in the Pacific Northwest, held July 10 and 11 in Seattle. Download PDF

Continue Reading

Posted July 8, 2013 by Matrix-Bio • No Comments


Matrix-Bio Options Metabolite Biomarker Technology from Purdue University to Evaluate Opportunities for New Cancer Diagnostic Tests

FORT WAYNE, IND., June 5, 2013 – Matrix-Bio Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive agreement with the Purdue Research Foundation optioning metabolite biomarker technology and eight patent applications to evaluate the commercial potential of cancer diagnostics tests based on the technologies. Download PDF

Continue Reading

Posted June 5, 2013 by Matrix-Bio • No Comments


To request information or an interview, contact:

Melanie Lux
PR & Marketing Director
Melanie@matrix-bio.com
803.331.4794


Matrix-Bio Overview Presentation

To download an overview presentation on Matrix-Bio, enter your email address and click Send Request.



Download Our Investor Profile

To download our Investor Profile, enter your email address and click Send Request.